Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2023-06-12 00:00:00 ET · period of report 2023-06-08 · accession 0001610717-23-000135 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-12 | 2023-06-08 | RVMD | Borisy Alexis | Dir | A - Grant | $0.00 | +5,200 | 239.8K | +2% | $0 |
| D | 2023-06-12 | 2023-06-08 | RVMD | Borisy Alexis | Dir | A - Grant | $0.00 | +18.4K | 18.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-08 | A | A | 5,200 | $0.00 | 239,822 | D | — | — | (F1) On August 17, 2022, December 7, 2022, and January 27, 2023, Third Rock Ventures GP III, L.P. distributed 17,220, 103,090 and 59,394 shares, respectively, to the Reporting Person through in-kind, pro rata distributions without value. The distributions were exempt Section 16 of the Exchange Act pursuant to Rule 16a-9. (F2) Includes 5,200 restricted stock units. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-06-08 | A | A | 18,400 | $0.00 | 18,400 | D | $24.84 · — to 2033-06-07 | 18,400 Common Stock | (F3) New Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 8, 2023 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date. |